glp-1 fda What Patients Need to Know About the Policy Changes FDA Approves Generic Version of

Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) have gone mainstream, backed by blockbuster results in weight loss trials and new approvals for conditions like obstructive sleep apnea

Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers

If you live outside of the US of A, you are likely not very familiar with Qysmia specifically

20%30% of patients receiving high-dose cisplatin will develop AKI, whose core diagnostic features are acute elevation of serum creatinine and rapid decline of Glomerular Filtration Rate (GFR), and up to 40%100% experience hypomagnesemia (Manohar and Leung 2018)

Which should you choose